Evidence map›Paper›PMID 26475583›Full record

Trial reportAmerican journal of physiology. Heart and circulatory physiology2015

Plasma levels of microRNA in chronic kidney disease: patterns in acute and chronic exercise.

Amaryllis H Van Craenenbroeck, Kristien J Ledeganck, Katrijn Van Ackeren, Angelika Jürgens, Vicky Y Hoymans, Erik Fransen, Volker Adams, Benedicte Y De Winter, Gert A Verpooten, Christiaan J Vrints and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of physiology. Heart and circulatory physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Non-coding RNAs in exercise immunology: A systematic review.Journal of sport and health science · 2024
    Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Exosomes and microRNAs as mediators of the exercise.European journal of medical research · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. miRNA biomarkers in renal disease.International urology and nephrology · 2022
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Exposure to metal fumes and circulating miRNAs in Algerian welders.International archives of occupational and environmental health · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Amaryllis H Van CraenenbroeckLaboratory of Cellular and Molecular Cardiology, Department of Cardiology, Antwerp University Hospital, Edegem, Belgium; Department of Nephrology, Antwerp University Hospital, Antwerp, Belgium; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium; amaryllis.vancraenenbroeck@uantwerpen.be.ORCID http://orcid.org/0000-0003-4728-9406
Kristien J LedeganckLaboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium;
Katrijn Van AckerenCardiovascular Diseases, Department of Translational Pathophysiological Research, University of Antwerp, Antwerp, Belgium;
Angelika JürgensLaboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium;
Vicky Y HoymansLaboratory of Cellular and Molecular Cardiology, Department of Cardiology, Antwerp University Hospital, Edegem, Belgium; Cardiovascular Diseases, Department of Translational Pathophysiological Research, University of Antwerp, Antwerp, Belgium;
Erik FransenStatUA Center for Statistics, University of Antwerp, Antwerp, Belgium; and.
Volker AdamsDepartment of Internal Medicine/Cardiology, University of Leipzig, Leipzig, Germany.
Benedicte Y De WinterLaboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium;
Gert A VerpootenLaboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium;
Christiaan J VrintsLaboratory of Cellular and Molecular Cardiology, Department of Cardiology, Antwerp University Hospital, Edegem, Belgium; Cardiovascular Diseases, Department of Translational Pathophysiological Research, University of Antwerp, Antwerp, Belgium;
Marie M CouttenyeDepartment of Nephrology, Antwerp University Hospital, Antwerp, Belgium;
Emeline M Van CraenenbroeckLaboratory of Cellular and Molecular Cardiology, Department of Cardiology, Antwerp University Hospital, Edegem, Belgium; Cardiovascular Diseases, Department of Translational Pathophysiological Research, University of Antwerp, Antwerp, Belgium;
University of Antwerp · BEAntwerp University Hospital · BELeipzig University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exercise training is an effective way to improve exercise capacity in chronic kidney disease (CKD), but the underlying mechanisms are only partly understood. In healthy subjects (HS), microRNA (miRNA or miR) are dynamically regulated following exercise and have, therefore, been suggested as regulators of cardiovascular adaptation to exercise. However, these effects were not studied in CKD before. The effect of acute exercise (i.e., an acute exercise bout) was assessed in 32 patients with CKD and 12 age- and sex-matched HS (study 1). miRNA expression in response to chronic exercise (i.e., a 3-mo exercise training program) was evaluated in 40 CKD patients (study 2). In a subgroup of study 2, the acute-exercise induced effect was evaluated at baseline and at follow-up. Plasma levels of a preselected panel miRNA, involved in exercise adaptation processes such as angiogenesis (miR-126, miR-210), inflammation (miR-21, miR-146a), hypoxia/ischemia (miR-21, miR-210), and progenitor cells (miR-150), were quantified by RT-PCR. Additionally, seven miRNA involved in similar biological processes were quantified in the subgroup of study 2. Baseline, studied miRNA were comparable in CKD and HS. Following acute exercise, miR-150 levels increased in both CKD (fold change 2.12 ± 0.39, P = 0.002; and HS: fold change 2.41 ± 0.48 P = 0.018, P for interaction > 0.05). miR-146a acutely decreased in CKD (fold change 0.92 ± 0.13, P = 0.024), whereas it remained unchanged in HS. Levels of miR-21, miR-126, and miR-210 remained unaltered. Chronic exercise did not elicit a significant change in the studied miRNA levels. However, an acute exercise-induced decrease in miR-210 was observed in CKD patients, only after training (fold change 0.76 ± 0.15). The differential expression in circulating miRNA in response to acute and chronic exercise may point toward a physiological role in cardiovascular adaptation to exercise, also in CKD.

Indexed as

AdultAgedAnaerobic ThresholdCell ProliferationDisease ProgressionExercise TestExercise TherapyFemaleGlomerular Filtration RateHumansHypoxiaInflammationKidney Function TestsMaleMicroRNAsMiddle AgedMicroRNAsacute exercisechronic kidney diseaseexercise trainingmicroRNA

Identifiers

PMID26475583
PMCPMC4698424
OpenAlexW2180300829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.